Clinical Trial Update: Topical Sirolimus in Cutaneous Lymphatic Malformations [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical sirolimus for cutaneous lymphatic malformations has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Malformation
• Vascular Malformation

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: University Hospital, Tours | Conditions: Vascular Malformations, Lymphatic Malformation | Phase 2 | Status: COMPLETED